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Garibaldi).The investigation of small interfering RNA (siRNA) and its posttranscriptional gene-regulation has
become an extremely important research topic, both for fundamental reasons and for potential longer-
term therapeutic beneﬁts. Several factors affect the functionality of siRNA including positional prefer-
ences, target accessibility and other thermodynamic features. State of the art tools aim to optimize the
selection of target siRNAs by identifying those that may have high experimental inhibition. Such tools
implement artiﬁcial neural network models as Biopredsi and ThermoComposition21, and linear regression
models as DSIR, i-Score and Scales, among others. However, all these models have limitations in perfor-
mance. In this work, a neural-network trained new siRNA scoring/efﬁcacy prediction model was devel-
oped based on combining two existing scoring algorithms (ThermoComposition21 and i-Score), together
with the whole stacking energy (DG), in a multi-layer artiﬁcial neural network. These three parameters
were chosen after a comparative combinatorial study between ﬁve well known tools. Our developed
model, ‘MysiRNA’ was trained on 2431 siRNA records and tested using three further datasets. MysiRNA
was compared with 11 alternative existing scoring tools in an evaluation study to assess the predicted
and experimental siRNA efﬁciency where it achieved the highest performance both in terms of correla-
tion coefﬁcient (R2 = 0.600) and receiver operating characteristics analysis (AUC = 0.808), improving
the prediction accuracy by up to 18% with respect to sensitivity and speciﬁcity of the best available tools.
MysiRNA is a novel, freely accessible model capable of predicting siRNA inhibition efﬁciency with
improved speciﬁcity and sensitivity. This multiclassiﬁer approach could help improve the performance
of prediction in several bioinformatics areas. MysiRNA model, part of MysiRNA-Designer package [1], is
expected to play a key role in siRNA selection and evaluation.
 2012 Elsevier Inc. All rights reserved.1. Introduction
Small interfering RNAs (siRNAs) are one of the cellular main
processes for posttranscriptional gene modiﬁcation, capable of
down regulating mRNA expression and causing targeted gene
silencing. These small RNA molecules are one of the cellular de-
fense mechanisms that act not only against exogenous genetic
material (such as viruses) but also against endogenous genes [2].
Due to their small length (19–21 nucleotides), they can bypass
the interferon-response responsible for undesirable cell death,
and hence are more capable of producing a desired silencing actionll rights reserved.
atics and Chemoinformatics
11 Cairo, Egypt. Fax: +2 02
c.uk, mm.abdelwahab@nrc.s-
wi), jmg@cs.nott.ac.uk (J.M.[3]. This induced gene silencing may be used to identify gene func-
tions or even (as an ultimate goal) to treat several gene-mediated
diseases such as cancer, AIDS and neurodegenerative disorders
for which no proper cure has yet been found [4–8].
In the last decade, siRNAs have become a major interest of many
biologists due to their selectivity and potency. This has resulted in
their therapeutic application for several viral-mediated diseases
such as Inﬂuenza A virus, HIV, Hepatitis B virus, and RSV viruses
and in cancer clinical trials [9–12]. As a result, siRNA silencing is
considered one of the most promising techniques in future ther-
apy, and predicting their inhibition efﬁciency is crucial for proper
siRNA selection. As a targeted gene could have thousands of poten-
tial siRNAs, ﬁnding the most active siRNA among them constitutes
a huge challenge facing researchers in this ﬁeld.
Several algorithms have been developed to predict siRNA
activity. However, only a few of them have achieved an acceptable
level of speciﬁcity and sensitivity. These algorithms could be
1 The software is a freeware, available online at http://www.cs.waikato.ac.nz/ml/
weka/.
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generation’ tools. The ﬁrst generation tools select the most efﬁcient
siRNAs based on differential ends thermodynamic stability
measures, mRNA secondary structure and base preferences speciﬁc
position target uniqueness; among these are Reynolds et al. [13],
Amarzguioui and Prydz [14], Takasaki et al. [15], Katoh and Suzuki
[16], Ui-Tei et al. [17], and Hsieh et al. [18]. However, these ﬁrst
generation tools were shown to have low accuracy, as up to 65%
of the siRNAs predicted as active failed to achieve 90% inhibition
when tested experimentally and up to 20% of them were found to
be inactive [19]. Consequently, it was perceived that there was a
need to develop techniques that incorporated machine-learning to
interpret and utilize the experimentally obtained data.
The second generation tools were developed by applying
sophisticated data mining techniques to interpret annotated re-
cords of siRNA with their experimental inhibition. It was not until
the introduction of the ‘Huesken’ dataset, used to train Biopredsi’s
artiﬁcial neural network model, that a breakthrough in the predic-
tion accuracy was attained [20]. Further improvement in predic-
tion accuracy was brought about by the use of a simpliﬁed linear
regression model in ‘DSIR’ [21]. ThermoComposition21 [22] com-
bined position dependent features together with thermodynamic
features in one artiﬁcial neural network model, hence, improving
the prediction accuracy. Two more models (i-Score and Scales
[23,24]) were developed that used simpler linear regression mod-
els to achieve similar levels of performance.
These second generation models (whether artiﬁcial neural net-
work or linear regression based) perform signiﬁcantly better than
the ﬁrst generation tools. However, the prediction accuracy and
statistical signiﬁcance of the ﬁve mentioned algorithms were
found to be very similar to each other when they were tested
against a new dataset that had not been used in their training as
reported in [23,24].
We investigated the top ﬁve scoring algorithms (Biopredsi, DSIR,
ThermoComposition21, i-Score and Scales), aiming to build a model
that combines their different scoring algorithms and features in a
single model in order to improve the prediction accuracy. In addi-
tion, we studied the effect of including whole stacking energy
(DG) as an independent parameter for enhancing the speciﬁcity
and sensitivity of siRNA efﬁciency prediction. Receiver operating
characteristics (ROCs) curve analysis, Matthews correlation coefﬁ-
cient (MCC) and Pearson’s correlation coefﬁcient (R2) were used
for the validation approach. This model was implemented in the
MysiRNA-Designer workﬂow package for selection and design of
efﬁcient siRNAs .
2. Material and methods
2.1. Dataset selection
In this work, the Huesken dataset (dataset A) was used to train
our model, the quality of this dataset is ensured by the Gaussian
distribution of their potencies [20,23]. Dataset A consists of 2431
siRNAs with their experimental inhibition efﬁciency, and has pre-
viously been used to train Biopredsi, DSIR, ThermoComposition21
and i-Score. Datasets B and C were used for validation step, where
dataset B consisted of 419 siRNA records from ﬁve different publi-
cations, Reynolds (60%), Vickers (18%), Haborth (11%), Ui-Tie (9%)
and Khovorova (2%). These datasets had been collected together
and published in the work of Ichihara in the development and eval-
uation of the i-Score software [23]. There are two versions of Ther-
moComposition, one for designing siRNA with length 19 mer, other
with 21 mer. Some records from dataset B were used to train Ther-
moComposition19 [22]. We ﬁltered dataset B and found 38 siRNA
unique records that were not involved in training of any of the
second generation tools, and these 38 records were used to createdataset C. Scoring of the siRNA datasets was performed using i-
Score designer that includes several ﬁrst and second generation
algorithms. To include the Scales prediction tool in our evaluation,
we calculated and added its predicted scores to each of the data-
sets A, B and C.
Another data was used consisting of nine genes with 18,593
siRNA presented by Fellmann et al. [29], in which each possible
siRNAs were designed and experimentally tested. The ratio be-
tween active and inactive siRNA was found to be (1:77), to over-
come the data being skewed to negative results, the positive
incidences were isolated (238) and randomly selected data from
the remaining, negative, data was isolated to form a total of 476
siRNA records, named dataset D (see Table 1). All these datasets
are available through supplementary ﬁle, named dataset A, B, C
and D, respectively.
2.2. Parameter selection
We investigated several second generation tools in an attempt
to build a model that combines several scoring techniques. We in-
cluded ﬁve models (Biopredsi, DSIR, ThermoComposition21, i-Score
and Scales) in our study and implemented each of these scores as
a parameter in our model. As in Ichihara’s work, we used the sim-
ulated Biopredsi (s-Biopredsi [23]) rather than the original Biopr-
edsi [20] due to the inaccessibility of the original model (the
correspondence between s-Biopredsi and Biopredsi was conﬁrmed
by achieving a Pearson correlation coefﬁcient of 1 and by achieving
identical receiver operating characteristics ROC analysis). We con-
sidered all possible combinations of models to determine whether
any provided an appreciable improvement in the prediction accu-
racy. After identifying that the best combination consisted of two
of the scores, we added a third parameter to our model, the whole
stacking energy (DG), evaluating its ability to further improve the
accuracy of results.
2.3. Training and validation
Due to the non-linear relationship between the selected
parameters, we could not apply linear regression to build our
model. Therefore, we built our model using multilayer artiﬁcial
neural networks implemented in WEKA software version 3.7.1
(Waikato Environment for Knowledge Analysis, University of
Waikato, NZ)1.
As a validation step we used the Pearson correlation coefﬁ-
cient to represent the correlation between the predicted and ac-
tual siRNA inhibition efﬁciency. In addition, we used receiver
operating characteristic (ROC) analysis that combines both sensi-
tivity and speciﬁcity by plotting the sensitivity (Y axis) against 1-
speciﬁcity (X axis). It is then possible to calculate the area under
the curve, known as the AUC, as a single measure of performance
(for which an AUC of 1 reﬂects perfect classiﬁcation and an AUC
of 0.5 reﬂects random classiﬁcation). Moreover, Matthews corre-
lation coefﬁcient (MCC) was also included. MCC is a correlation
coefﬁcient between the observed and predicted binary classiﬁca-
tions; taking into account false positive (FP), false negative (FN),
true positive (TP) and true negative (TN), it returns a value be-
tween 1 (negative correlation), 0 (no correlation) and +1 (posi-
tive correlation).
MCC ¼ TP TN FP FNﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃðTPþ FBÞðTPþ FNÞðTNþ FPÞðTNþ FNÞp ð1Þ
Table 1
Comparison between datasets A, B, C and D. Comparison between Dataset A, B, C and D illustrating their source, instance where they were used to for model training and testing
models. Further analysis of these data showing their size, number of records with percentage inhibition between (50% and 70%), (70% and 90%), (above 90%) and number of genes
involved in each dataset. This analysis illustrate the uniformity of each dataset and illustrate the instance where over ﬁtting of the data might occur.
Dataset
Name
Dataset source Train set for Test set for Size 50–70%
inhibition
70–90%
inhibition
>90%
inhibition
Num of
genes
Dataset A Novartis All of the 2nd generation
tools +MysiRNA
Biopredsi,
DSIR
2431 778 853 369 30
Dataset B Reynold, Vickers, Haborth,
Ui-Tie, Khovorova
Thermo Composition19 i-Score,
Scales
419 60 117 96 12
Dataset C* Records extracted from
Dataset B
None i-Score,
Scales
38 7 12 19 7
Dataset D Fellmann et al. [29] None – 476 70 53 127 9
* Dataset C extracted from Dataset B by ﬁltering siRNA records used from training ThermoComposition19, forming 38 unique siRNA records that has not been used for
training any of the second generation tools previously.
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3.1. Parameters selection
Since the siRNA design and scoring tools use different features
and weights in the design process, combining these features by
building a model containing these scores was attempted. The pre-
dicted scores for each of the ﬁve algorithms against database A was
used as parameters to build models considering all possible combi-
nations. The combinations consisted of either two, three, four and
ﬁve tools, resulting in 25 possible combinations in total (Table 2).Table 2
Different combinations of tools and their predicti
the results all possible combination of different s
using both ROC analysis and Pearson correlation
accuracy was achieve by the model combing T
implemented in MysiRNA. (A) s-Biopredsi model,
i-Score model, E: Scales model black cells = no linBoth linear regression and artiﬁcial neural networks (ANNs) were
used to combine each model, and used to perform a comparative
analysis between these models and their prediction accuracy
against database B and C.
It was found that among these, the model that combines Ther-
moComposition21 and i-Score produced the most accurate results,
irrespective of whether linear combination or non-linear (ANN)
combination was used. For each combination, the prediction accu-
racy evaluated by either Pearson correlation coefﬁcient or AUC
achieved the highest score (Fig. 1).on accuracy against dataset B. Illustration of
coring tools their analysis against dataset B
coefﬁcient for evaluation. Where the highest
hermoComposition21 and i-Score was later
(B) DISR model, (C) ThermoComposition21, (D)
ear correlation. Yellow = best combination.
Fig. 1. Comparison between three proposed models, indicating the most accurate model among them. (A) model (blue color) combines i-Score + ThermoComposi-
tion21 + whole DG in ANN model. (B) Model (Dark red color) combines i-Score and ThermoComposition21 in linear regression model. (C) Model (Green color) combines i-Score
and ThermoComposition21 in ANN model. The results were evaluated by both Pearson correlation coefﬁcient (Chart I) and ROC analysis (Chart II) including dataset A, B and C.
It was found that ANNmodel of ThermoComposition21 + i-Score + whole DG has the best performance among them. (For interpretation of the references to colour in this ﬁgure
legend, the reader is referred to the web version of this article.)
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Whole DG was included as an independent parameter to our
proposed model. When the three parameters (ThermoComposi-
tion21, i-Score and whole DG) were combined using an ANN, a
noticeable improvement in the prediction accuracy was obtained.
After optimizing the ANN models, this non-linear combination
resulted in a Pearson correlation of 0.600 and AUC of 0.808 be-
tween the predicted and experimental siRNA efﬁciency, for dataset
B (Fig. 1). We term this model ‘MysiRNA’.
3.3. Comparing MysiRNA with the second generation algorithms
To test the efﬁciency of the developed model (MysiRNA), data-
base B was used in a comparative analysis with other second gen-
eration algorithms (Biopredsi, DSIR, ThermoComposition21, i-Score
and Scales). The actual siRNA activity was plotted against the pre-
dicted activity byMysiRNA and each of these ﬁve techniques, one at
a time. The prediction accuracy was veriﬁed using Pearson correla-
tion coefﬁcient and AUC. From examination of the Pearson correla-
tion coefﬁcient, MysiRNA achieved better correlation with the
experimental data against the other techniques (Fig. 2) and
brought improvement to the AUC (AUC = 0.808), using 70% as a
threshold for siRNA efﬁciency acceptance (Fig. 3).
3.4. Evaluating MysiRNA model against ﬁrst and second generation
algorithms
Another experiment was then conducted to compare MysiRNA
with ﬁrst generation tools including Reynolds, Amarzguioui, Katoh,
Hsieh, Takasaki and Ui-Tie, and with second generation tools s-
Biopredsi, DSIR, ThermoComposition21 and i-Score, using all three
datasets. The results were then analyzed using Pearson correlation
coefﬁcient and AUC. In the ROC analysis, siRNA with inhibition
equal to 70% or above is considered active siRNA and below 70%
are considered inactive (Fig. 4). As some of the datasets had been
used to train certain tools, there was a possibility of over-ﬁttingsuch that the performance could have been overestimated. Hence,
we used Dataset C that is pure/non-biased set. It was found that
the MysiRNA model provided the most accurate prediction results
compared to the 11 models included in this experiment, achieving
AUCs of 0.855, 0.808 and 0.834, and Pearson correlations of 0.687,
0.600 and 0.699, against dataset A, B and C, respectively.
To evaluate any beneﬁt of MysiRNA over the other models indi-
vidually, a comparative study was performed between the in-
stances where each of the second-generation models failed to
predict siRNA activity, whileMysiRNA succeeded. It was found that
MysiRNA increases the prediction capabilities of all of the second
generation tools by between 3% and 18% (Table 3).
3.5. Mathew correlation coefﬁcient for models evaluation
Another comparative analysis was performed involving Mys-
iRNA, ﬁrst generation and second generation models using dataset
D, where MCC was used to illustrate the statistical difference be-
tween all of the models involved. A threshold of 85% was applied
as a cut-off score, above which the prediction is positive and below
this threshold siRNA considered inactive. MysiRNA achieved the
highest MCC with the experimentally veriﬁed data, as it was able
to achieve a correlation of 0.51, while the others achieved smaller
correlations, see (Table 4). For further details refer to the Supple-
mentary data.4. Discussion
A number of differentmodels have previously been developed to
evaluate siRNA efﬁciency and predict their inhibition activity. In
this work, we studied the best scoring techniques currently avail-
able, and their corresponding algorithms, searching for amodel that
combines the predicted results of these tools to producemore accu-
rate prediction.
We found that combining ThermoComposition21 with i-Score
produced the most accurate model among the different combina-
tions of models tested. In addition, we tested the effect of including
Fig. 2. Comparison between the second generation models and MysiRNA Model using Pearson correlation analysis. Experimental siRNAs activities of dataset B (which has
never been used to train any of these scoring models) were plotted against the predicted siRNAs activities by each of the second general scoring tools (s-Biopredsi, DSIR,
ThermoComposition21, i-Score and Scales) together with MysiRNA model. Pearson correlation coefﬁcient (r) was calculated for each of the six scoring tools. Pearson correlation
coefﬁcient of MysiRNA model showed improvement in the performance compared to the other ﬁve models. Dataset B was included in this analysis as it was not used for
training of any of the six models to avoid over ﬁtting.
Fig. 3. ROC analysis showing area under the curve of the second generation tools
and MysiRNA. Comparative analysis including s-Biopredsi, DSIR, ThermoComposi-
tion21, i-Score, Scales and MysiRNA to test the sensitivity (Y axes) and 1- speciﬁcity
(X axes) of the predicted results with of these tools. The level of speciﬁcity and
sensitivity is slightly improved by using MysiRNA compared to the other tools as
MysiRNA scored 0.808 compared to the AUC achieved by s-Biopredsi, DSIR,
ThermoComposition21, i-Score and Scales (0.782,0 .792, 0.794, 0.756, 0.781)
respectively.
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tween siRNA duplexes) to our designed model. This resulted in a
model with even better performance.
The Thermocomposition21 algorithm is based on three different
parameters, the ‘position dependant consensus’, the ‘dinucleotide
content index’ and the ‘thermodynamic proﬁle’. The position
dependent consensus depends on the identiﬁcation of several
desirable and undesirable residues, the dinucleotide content index
is based on the number of dinucleotide combinations exceeding
the random distribution, and the thermodynamic proﬁle is related
to the difference in free energy between 50 and 30 [22]. Meanwhile,
the i-Score algorithm is based on annotated position dependent
residues G/C at position (18, 19) and A/T stretch at the 50 end of
the antisense and other parameters that have been previously
identiﬁed [20,22,25,26]. The fact that these two scores incorporate
different features may explain why a combination of the two pro-
duces better performance.
Whole siRNA stacking energy (Gibbs energy, DG) reﬂects the
stability of siRNA duplex [27]. It depends on the stacking energy
difference between each dinucleotide and their complementary
nucleotides in the siRNA duplex. It has been shown that there is
a correlation between siRNA inhibition efﬁciency and whole stack-
ing energy [23,28]. While whole DG was found to not be of beneﬁt
within the i-Score model [23], we suggest that this could be due to
the fact that the non-linear correlation between whole DG and the
other parameters could not be adequately represented within i-
Score’s linear model. However, the addition of DG as a standaloneparameter to the MysiRNA model appreciably enhanced the pre-
diction of the model (the Pearson correlation increased from
0.581 to 0.600).
Fig. 4. Comparative studies between MysiRNA, ﬁrst and second generation tools. Comparison between 12 different tools using ROC & Pearson correlation coefﬁcient against
dataset A, B and C. The enhancement brought by the second generation tool proven from the ﬁnding of this analysis. Additionally, MysiRNA was found to perform with high
level of speciﬁcity and sensitivity compared to the other models. In cases the mark (1) indicates possible result overestimation, due to the use of concerned dataset in the
training of the model.
Table 3
Comparative study between MysiRNA Model and each of the second generation tools. The results illustrate the common true positive and common true negative between
MysiRNA and each of the second generation models. Further analysis for was performed for instances showing the enhancement brought by MysiRNA in numerical and
percentage against dataset B which has not been used to any model training.
2nd Generation tool Number of TP and TN in
common
Number of FP and FN in
common
Number of TP/TN by
MysiRNA and FN/FP by 2nd
generation tool
Number of FP/FN
by MysiRNA and
TN/TP by
2nd generation
tool
% Improvement brought by
MysiRNA (%)
s-Biopredsi 249 79 58 33 6
DSIR 278 94 29 18 3
ThermoComposition21 279 96 28 16 3
i-Score 165 44 142 68 18
Scales 264 94 43 18 6
Table 4
Mathew correlation coefﬁcient comparative analysis. Data of 18,593 recently presented in [25] was used in a comparative analysis involving Ui-Tei, Amarzguioui, Hsieh, Takasaki,
Biopredsi, i-Score, Reynolds, Katoh, DSIR and ThermoComposition21, siRNA Scales and MysiRNA models. All the positive records were isolated and combined with negative
records of the same size, to test these models. Mathew correlation coefﬁcient (MCC) was used to illustrate the statistical differences between the models involved.
476 Records Ui-Tei Amar Hsieh Taka Biopred i-Score Rey Katoh DSIR Thermo21 Scales MysiRNA
Senstitive 0.26 0.06 0.00 0.02 0.18 0 0.067 0.3 0.44 0.4 0.34 0.64
Speciﬁcity 0.95 0.99 0.99 0.99 0.98 1 0.98 0.89 0.94 0.91 0.94 0.86
mmc 0.29 0.12 0 0.05 0.26 – 0.13 0.23 0.43 0.37 0.35 0.51
TP 61 14 1 6 43 0 16 72 105 96 81 153
FN 177 224 237 232 195 238 222 166 133 142 157 85
TN 226 235 237 235 233 238 234 211 223 217 224 204
FP 12 3 1 3 5 0 4 27 15 21 14 34
M. Mysara et al. / Journal of Biomedical Informatics 45 (2012) 528–534 533Three validation experiments were conducted to test our pro-
posed model using Pearson correlation coefﬁcient, ROC analysis
and MCC for validation. In these comparative studies, it was foundthat our MysiRNA model is able to predict siRNA inhibition efﬁ-
ciency with better speciﬁcity and selectivity than any previous
model.
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This work introducesMysiRNA, featuring an artiﬁcial neural net-
work model, to predict siRNA inhibition activity, built on two pre-
vious models (ThermalComposition21 and i-Score) and whole
stacking energy (DG). It may be considered as an example of suc-
cessfully combining different machine learning methods (classiﬁ-
ers) to improve the prediction accuracy compared to previously
designed models. This illustrates the improvement in performance
that can sometimes be achieved by incorporating different models
in a non-linear model combination. As has previously been shown
in other areas of bioinformatics, the importance of consensus re-
sults (combining results between various algorithms) appears to
be valid here. MysiRNA score is implemented in our siRNA design
software, MysiRNA-Designer [1], where it was found able to boost
the speciﬁcity from 93% to 97%. MysiRNA WEKA Model is freely
available in the supplementary data with the Perl script to run it.
It is expected that MysiRNA may become widely used for siRNA
selection. In addition, the approach of combining multiple classiﬁ-
ers used here could help improve the performance of prediction in
similar areas of bioinformatics.
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